Garry Menzel

Garry Menzel

Chief Executive Officer presso TCR2 THERAPEUTICS INC.

Patrimonio netto: 541 818 $ in data 29/02/2024

59 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Presently, Garry E.
Menzel
occupies the position of Chief Executive Officer at TCR2 Therapeutics, Inc. He is also on the board of Epilepsy Therapy Project, Adaptimmune Therapeutics Plc, Stoke Therapeutics, Inc. and Black Diamond Therapeutics, Inc. and Member-National Board at Epilepsy Foundation and Principal at Royal College of Art.
In his past career Dr. Menzel held the position of Chief Operating Officer for Regulus Therapeutics, Inc., Chief Financial Officer at DaVita, Inc., Managing Director at The Goldman Sachs Group, Inc., Consultant at Bain & Co., Inc., Chief Strategy Officer at Axcella Health, Inc., Research Assistant at Smithkline Beecham Plc and Managing Director at Credit Suisse Group AG.
He received an undergraduate degree from Imperial College London, an MBA from Stanford Graduate School of Business and a doctorate from the University of Cambridge.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
16/05/2023 76 644 ( 0.15% ) 394 333 $ 29/02/2024
10/07/2023 563 522 ( 0.10% ) 147 485 $ 29/02/2024
01/09/2023 0 ( -.--% ) - $ 29/02/2024

Posizioni attive di Garry Menzel

SocietàPosizioneInizio
TCR2 THERAPEUTICS INC. Chief Executive Officer 01/01/2016
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 01/01/2014
STOKE THERAPEUTICS, INC. Director/Board Member 13/08/2020
ADAPTIMMUNE THERAPEUTICS PLC Director/Board Member 01/06/2023
Corporate Officer/Principal 01/01/2003
Epilepsy Therapy Project Director/Board Member -
Royal College of Art Corporate Officer/Principal 17/03/2010
Tutte le posizioni attive di Garry Menzel

Precedenti posizioni note di Garry Menzel

SocietàPosizioneFine
AXCA HEALPAR Corporate Officer/Principal 01/09/2016
DAVITA INC. Director of Finance/CFO 30/03/2015
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Garry Menzel

Formazione di Garry Menzel

Imperial College London Undergraduate Degree
University of Cambridge Doctorate Degree
Stanford Graduate School of Business Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Garry Menzel

Relazioni

100 +

Relazioni di 1° grado

18

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
DAVITA INC.

Health Services

THE GOLDMAN SACHS GROUP, INC.

Finance

REGULUS THERAPEUTICS INC.

Health Technology

AXCA HEALPAR

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

Aziende private9

Health Technology

Finance

Commercial Services

Commercial Services

Commercial Services

Epilepsy Therapy Project

Health Technology

Black Diamond Therapeutics, Inc.

Adaptimmune Therapeutics Plc

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Garry Menzel